Lysis pneumonopathy associated with the use of fludarabine phosphate.
Crowley
J J
JJ
Pulmonary Section, Department of Veterans Affairs (VA) Medical Center, Boise, Idaho 83702-4598.
Knight
L
L
Charan
N
N
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy; D008297:Male; D012131:Respiratory Insufficiency / Q000209:etiology*; D015275:Tumor Lysis Syndrome / Q000150:complications / Q000209:etiology*; D001084:Vidarabine Phosphate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate